MedPure Weight-Loss

MedPure Weight-Loss operates as a Georgia-focused telehealth practice under the medical direction of Dr. Gidon Akler, MD, FACMG, a physician board-certified by the American Board of Medical Genetics and Genomic Medicine. Based in Alpharetta, GA, the clinic provides virtual consultations for patients across Georgia seeking medically supervised weight management through GLP-1 receptor agonist therapy. Dr. Akler applies his background in medical genetics to weight loss treatment, recognizing that metabolic response, body composition changes, and medication tolerance vary significantly among individuals based on genetic and physiologic factors.

The clinic's treatment protocol centers on two FDA-approved peptide medications: semaglutide and tirzepatide. Semaglutide functions as a GLP-1 receptor agonist that regulates appetite and glucose metabolism, while tirzepatide acts on both GLP-1 and GIP receptors for dual incretin effect. Dr. Akler initiates patients on individualized dosing schedules, typically starting with lower doses and titrating upward based on tolerance and response. The practice monitors body composition changes throughout treatment, tracking not only total weight reduction but also preservation of lean muscle mass and reduction in body fat percentage. Patients receive guidance on protein intake and resistance training strategies to maintain muscle tissue during caloric deficit, addressing a common concern in rapid weight loss protocols.

Dr. Akler conducts initial consultations via secure telehealth platform, reviewing medical history, current medications, weight loss goals, and any contraindications to GLP-1 therapy. His genetics training informs his approach to identifying patients who may experience enhanced response or require modified protocols based on metabolic factors. Following the initial evaluation, patients who qualify for treatment receive prescriptions coordinated through partner pharmacies, with medications shipped directly to their Georgia address. The clinic provides detailed injection technique instruction and manages dosage adjustments through monthly follow-up appointments conducted virtually.

Patients enrolled in MedPure Weight-Loss programs participate in ongoing monitoring that includes weight tracking, side effect assessment, and body composition evaluation. Dr. Akler adjusts medication dosing based on individual response patterns, tolerance to gastrointestinal effects, and rate of weight reduction. The practice emphasizes sustainable outcomes rather than maximum speed of weight loss, aiming to preserve metabolic health and muscle mass throughout treatment. Patients receive access to Dr. Akler between scheduled appointments for questions regarding dosage timing, management of side effects, or concerns about treatment response. The monthly monitoring structure allows for real-time protocol adjustments as patients progress through different phases of weight reduction.

MedPure Weight-Loss serves patients throughout Georgia via telehealth, eliminating travel requirements to the Alpharetta area while maintaining continuity of care under Dr. Akler's supervision. The virtual care model accommodates patients with scheduling constraints, those in rural areas of Georgia without local access to peptide therapy providers, and individuals who prefer the convenience of home-based treatment. The practice maintains a 4.8-star rating across 54 Google reviews, with patients discussing their experience with semaglutide protocols, body composition changes, dosage management, and confidence improvements associated with weight reduction. Dr. Akler's approach combines his medical genetics expertise with practical weight management strategies, offering Georgia residents access to physician-supervised GLP-1 therapy without the need for in-person clinic visits.